Global Preclinical Cell and Gene Therapy Lead, and Head of Toxicology Subject Matter Experts, Safety Assessment/Toxicology, Labcorp
BIOGRAPHY
Speakers
-
Tracy Iles, BSc
Global Head of Method Development, Molecular Bioanalysis, LabcorpBIOGRAPHY -
Jay Herman, PhD
Toxicology Specialist, Study Director, LabcorpBIOGRAPHY -
Peter Sonnentag, MS
Study Director and Preclinical Ocular Toxicology Lead, LabcorpBIOGRAPHY -
Colin Guy, PhD
Senior Manager, GMP Research and Development, Biopharmaceutical CMC SolutionsBIOGRAPHY
Abstract
Watch the first of a three-part roundtable series that focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders.
In this roundtable, the panel discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy. Specific areas of focus include:
In this roundtable, the panel discuss novel innovations and strategies to accelerate timelines within preclinical development of your gene therapy. Specific areas of focus include:
-
Optimizing analytical test development and validation for dose analysis, molecular bioanalysis, transgene bioanalysis and immunogenicity, etc.
-
Utilizing unique in vivo models requiring complex methods and routes of administration (e.g., intracranial, or ocular delivery, disease, or immunosuppressed models)
-
Driving cross-industry collaboration to support accelerating timelines and reducing risk
Watch roundtable 1: Key Considerations for Driving Gene Therapy Programs Successfully Through IND/CTA and Beyond
Watch roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies
Watch roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies
Watch roundtable 2: Accelerating Cell Therapy Clinical Trials With Comprehensive Biomarker-Driven Strategies
Watch roundtable 3: Companion Diagnostic Approaches in the Development of Cell and Gene Therapies